An agency of the European Union
Frequent searches:
The European Centre for Disease Prevention and Control (ECDC) assesses the risk to the general population in the European Union and European Economic Area (EU/EEA) of invasive meningococcal disease (IMD) related to the outbreak in Kent, England, as very low due to the very small probability of exposure and infection.
As of March 2026, over 1 000 confirmed and possible cases of shigellosis and other gastrointestinal infections, including salmonellosis, have been detected in travellers returning from Cabo Verde to several countries in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US), with new cases still being reported.
In this episode, we speak with microbiologists Theresa Enkirch and Maximilian Riess who explain how wastewater surveillance works and why it is becoming increasingly valuable for public health.
This e-learning course equips public health communicators with skills to effectively convey the benefit and risk balance of vaccination to diverse audiences.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of mpox in its weekly threat report.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, chikungunya, mass gathering monitoring, and mpox.
Communicable disease threats report, 7 – 13 March 2026 , week 11
English (1.18 MB - PDF)
Respiratory virus trends across the EU/EEA continue to show early signs of decline. RSV circulation remains high, with children under five most affected. Influenza circulation and hospitalisations are decreasing. SARS CoV 2 activity remains low.
In July 2022, the European Commission adopted the proposal for a Regulation on standards of quality and safety for substances of human origin (SoHO) intended for human application.
Our vision is to be a more sustainable and resource-efficient agency.
EMAS Policy
English (1.41 MB - PDF)
Between 29 November 2025 and 27 February 2026, 2514 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (406) and wild (2108) birds in 32 countries in Europe.
Avian influenza overview December 2025–February 2026
English (1.94 MB - PDF)
Explore the critical role of behavioural and social research in understanding, controlling, and preventing infectious diseases.
The European Commission has issued four new calls for applications for the designation of EU Reference Laboratories (EURLs) for public health.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
Reporting Protocol for integrated respiratory virus surveillance, version 1.12
English (1.56 MB - PDF)
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
On 7 August 2027, the provisions of Regulation (EU) 2024/1938 on standards of quality and safety for substances of human origin (SoHO Regulation) becomes applicable.
Today, the European Centre for Disease Prevention and Control, ECDC, and the Africa Centres for Disease Control and Prevention, Africa CDC, signed their first Memorandum of Understanding to strengthen health security in Africa and Europe.
Since the previous update on 3 February 2026, and as of 2 March 2026, no new MERS cases have been reported by the World Health Organization (WHO) or national health authorities.
External experts complement ECDC’s scientific expertise and assist ECDC with expert advice on specific tasks.
Since April 2012, and as of 2 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.